miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma (Q39000946)

8 September 2017

miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma (English)

1 reference

8 September 2017

1 reference

W Gao

1

1 reference

8 September 2017

Y Gu

2

1 reference

8 September 2017

Z Li

3

1 reference

8 September 2017

H Cai

4

1 reference

8 September 2017

Q Peng

5

1 reference

8 September 2017

M Tu

6

1 reference

8 September 2017

Y Kondo

7

1 reference

8 September 2017

K Shinjo

8

1 reference

8 September 2017

Y Zhu

9

1 reference

8 September 2017

J Zhang

10

1 reference

8 September 2017

Y Sekido

11

1 reference

8 September 2017

B Han

12

1 reference

8 September 2017

Z Qian

13

1 reference

8 September 2017

Y Miao

14

1 reference

8 September 2017

language of work or name

English

0 references

publication date

28 April 2014

1 reference

8 September 2017

1 reference

8 September 2017

34

1 reference

8 September 2017

1629-1640

1 reference

8 September 2017

13

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2014.101

8 September 2017

0 references

cites work

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNA therapeutics in preclinical cancer models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNA regulation by RNA-binding proteins and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

DNA methylation screening identifies driver epigenetic events of cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Epigenetic regulation of microRNAs in cancer: an integrated review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Methylation of human microRNA genes in normal and neoplastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Investigation of IGF2/ApaI and H19/RsaI polymorphisms in patients with cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNAs and epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Characterization and identification of microRNA core promoters in four model species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

IGF2: epigenetic regulation and role in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Effect of CpG island methylation on microRNA expression in the k-562 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Methyl-DNA immunoprecipitation (MeDIP): hunting down the DNA methylome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Relaxation of imprinted genes in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Transcriptomic analysis of Paulownia infected by Paulownia witches'-broom Phytoplasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.101

DNA methylation regulates MicroRNA expression

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24769899

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2014.101

1 reference

8 September 2017

1 reference